SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BioStock Values SynAct’s Resomelagon Across Three Indications at SEK 2.9B

BioStock’s BioVal analysis estimates a combined value of SEK 2.9 billion across three indications for SynAct’s resomelagon.

Related stories